Subscribe to Newsletter

July 2018 Issue of The Medicine Maker

“Welcome to the July issue. Upfront investigates a new approach to making cancer drugs cheaper – with a paper ‘coffee’ filter; and a new report suggesting trust in pharma is nosediving. Tommy Fanning argues that Ireland’s biopharma sector will continue to thrive in light of US tax cuts and Brexit, in “In My View”, while our cover feature examines the future of the Chinese pharmaceutical industry, and what Made in China 2025 might mean for the rest of the world. Our second feature provides hard data, expert insight, and thoughts for the future of biopharma in the first of our three part series on Biopharma Trends. We also Sit Down With Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Manufacture Vaccines

Jurassic Medicine

| Stephanie Vine

No dinosaurs were harmed in the making of this vaccine…

Manufacture Business Practice

There’s Something in the Water

| Roisin McGuigan

Drug emissions in UK rivers raise questions about long-term consequences for the environment.

Discovery & Development Contract Development Services

A Nice Outsourcing View

| Stephanie Vine

What is the current state of pharma contract development and manufacturing?

Discovery & Development Analytical Science

Pure and Simple(r)

| Stephanie Vine

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

Business & Regulation Business Practice

In Pharma We (Don’t) Trust

| Roisin McGuigan, Joanna Cummings

Consumer trust in pharma nosedives because of the “blame game.”

Discovery & Development Contract Development Services

Trials of a Medicine Maker

What is the current state of pharma contract development and manufacturing?

Business & Regulation Standards & Regulation

Ireland’s Brexit Trump Card

| Tommy Fanning

Tommy Fanning believes that Ireland’s pharma industry will continue to thrive, despite tax cuts in the US and Brexit.

Discovery & Development Standards & Regulation

The End of “Mini-Me” Medicine

| Andrew Parker

The end of “mini me” medicine is over, says Andrew Parker, because we can do better when it comes to pediatric care.

Manufacture Small Molecules

Faster, Cheaper, Better

| Maria Luisa Palacios-Alcolado

Catalysis is increasingly being adopted by pharma because it can bring down costs.

Manufacture Business Practice

Make China Great Again

| James Strachan

China is upping its game with plans to revolutionize its manufacturing industries, including pharma.

Business & Regulation Business Practice

All Eyes on Biopharma Trends

| Stephanie Vine, Roisin McGuigan

We examine the most commercially important biotherapeutics now, and in the future.

Manufacture Advanced Medicine

At the Immuno-Oncology Frontier

| Bryan (Bo) Barnhart

Meet Bristol-Myers Squibb’s Bryan (Bo) Barnhart, who is a passionate advocate for the immuno-oncology field.

Manufacture Bioprocessing - Upstream & Downstream

It’s a Vendor’s Life: Lessons Learned with Rick Morris

| Rick Morris

Rick Morris shares lessons learned based on a career of polymers and building biopharma equipment.

Business & Regulation Business Practice

The Successful Experiment

Sitting Down With... Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry (ABPI), UK.

Other issues of 2018